Global Neurokinin Receptor Antagonists API Market Growth 2026-2032
The global Neurokinin Receptor Antagonists API market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Neurokinin receptor antagonists API (active pharmaceutical ingredient) refers to the biologically active compounds that inhibit the action of neurokinins by blocking their respective receptors, primarily neurokinin-1 (NK1) and neurokinin-3 (NK3) receptors. These antagonists are designed to counteract the effects of neuropeptides such as substance P and neurokinin B, which are involved in various physiological processes, including the regulation of nausea, vomiting, pain perception, and mood.
United States market for Neurokinin Receptor Antagonists API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Neurokinin Receptor Antagonists API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Neurokinin Receptor Antagonists API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Neurokinin Receptor Antagonists API players cover Dr. Reddy's Laboratories, Glenmark Life Sciences, Jubilant Pharmova, Murli Krishna Pharma, MSN Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Neurokinin Receptor Antagonists API Industry Forecast” looks at past sales and reviews total world Neurokinin Receptor Antagonists API sales in 2025, providing a comprehensive analysis by region and market sector of projected Neurokinin Receptor Antagonists API sales for 2026 through 2032. With Neurokinin Receptor Antagonists API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurokinin Receptor Antagonists API industry.
This Insight Report provides a comprehensive analysis of the global Neurokinin Receptor Antagonists API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurokinin Receptor Antagonists API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurokinin Receptor Antagonists API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurokinin Receptor Antagonists API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurokinin Receptor Antagonists API.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurokinin Receptor Antagonists API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Neurokinin Receptor Antagonists API market?
What factors are driving Neurokinin Receptor Antagonists API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurokinin Receptor Antagonists API market opportunities vary by end market size?
How does Neurokinin Receptor Antagonists API break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Neurokinin receptor antagonists API (active pharmaceutical ingredient) refers to the biologically active compounds that inhibit the action of neurokinins by blocking their respective receptors, primarily neurokinin-1 (NK1) and neurokinin-3 (NK3) receptors. These antagonists are designed to counteract the effects of neuropeptides such as substance P and neurokinin B, which are involved in various physiological processes, including the regulation of nausea, vomiting, pain perception, and mood.
United States market for Neurokinin Receptor Antagonists API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Neurokinin Receptor Antagonists API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Neurokinin Receptor Antagonists API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Neurokinin Receptor Antagonists API players cover Dr. Reddy's Laboratories, Glenmark Life Sciences, Jubilant Pharmova, Murli Krishna Pharma, MSN Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Neurokinin Receptor Antagonists API Industry Forecast” looks at past sales and reviews total world Neurokinin Receptor Antagonists API sales in 2025, providing a comprehensive analysis by region and market sector of projected Neurokinin Receptor Antagonists API sales for 2026 through 2032. With Neurokinin Receptor Antagonists API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurokinin Receptor Antagonists API industry.
This Insight Report provides a comprehensive analysis of the global Neurokinin Receptor Antagonists API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurokinin Receptor Antagonists API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurokinin Receptor Antagonists API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurokinin Receptor Antagonists API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurokinin Receptor Antagonists API.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurokinin Receptor Antagonists API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Fezolinetant
- Aprepitant
- Rolapitant
- Fosaprepitant
- Netupitant
- Maropitant
- Tablets
- Capsules
- Oral Suspension
- Injections
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Dr. Reddy's Laboratories
- Glenmark Life Sciences
- Jubilant Pharmova
- Murli Krishna Pharma
- MSN Laboratories
- Optimus Pharma
- Piramal Pharma
- Solara Active Pharma Sciences
- Camus Pharma
- Clearsynth Labs
- Helsinn Advanced Synthesis
- Procos
- Andenex
- Taizhou Crene Biotechnology
- Zydus Animal Health And Investments
- Wisdom Pharmaceutical
- Zhejiang Tiantai Pharmaceutical
- Qilu Pharmaceutical
- Kelun Pharmaceutical
- Hansoh Pharma
- Luoxin Pharmaceuticals
- Hangzhou Jiuyuan Gene Engineering
- Lianyungang Runzhong Pharmaceutical
- Viwit
- Humanwell Pharmaceutical
- Shandong Anxin Pharmaceutical
- Beijing Sjar Technology Development
- Sichuan Qingmu Pharmaceutical
- Shandong New Time Pharmaceutical
- United Pharma
What is the 10-year outlook for the global Neurokinin Receptor Antagonists API market?
What factors are driving Neurokinin Receptor Antagonists API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurokinin Receptor Antagonists API market opportunities vary by end market size?
How does Neurokinin Receptor Antagonists API break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurokinin Receptor Antagonists API Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Neurokinin Receptor Antagonists API by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Neurokinin Receptor Antagonists API by Country/Region, 2021, 2025 & 2032
2.2 Neurokinin Receptor Antagonists API Segment by Type
2.2.1 Fezolinetant
2.2.2 Aprepitant
2.2.3 Rolapitant
2.2.4 Fosaprepitant
2.2.5 Netupitant
2.2.6 Maropitant
2.2.7 Neurokinin Receptor Antagonists API Sales by Type
2.2.7.1 Global Neurokinin Receptor Antagonists API Sales Market Share by Type (2021-2026)
2.2.7.2 Global Neurokinin Receptor Antagonists API Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Neurokinin Receptor Antagonists API Sale Price by Type (2021-2026)
2.3 Neurokinin Receptor Antagonists API Segment by Application
2.3.1 Tablets
2.3.2 Capsules
2.3.3 Oral Suspension
2.3.4 Injections
2.3.5 Other
2.3.6 Neurokinin Receptor Antagonists API Sales by Application
2.3.6.1 Global Neurokinin Receptor Antagonists API Sale Market Share by Application (2021-2026)
2.3.6.2 Global Neurokinin Receptor Antagonists API Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Neurokinin Receptor Antagonists API Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Neurokinin Receptor Antagonists API Breakdown Data by Company
3.1.1 Global Neurokinin Receptor Antagonists API Annual Sales by Company (2021-2026)
3.1.2 Global Neurokinin Receptor Antagonists API Sales Market Share by Company (2021-2026)
3.2 Global Neurokinin Receptor Antagonists API Annual Revenue by Company (2021-2026)
3.2.1 Global Neurokinin Receptor Antagonists API Revenue by Company (2021-2026)
3.2.2 Global Neurokinin Receptor Antagonists API Revenue Market Share by Company (2021-2026)
3.3 Global Neurokinin Receptor Antagonists API Sale Price by Company
3.4 Key Manufacturers Neurokinin Receptor Antagonists API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurokinin Receptor Antagonists API Product Location Distribution
3.4.2 Players Neurokinin Receptor Antagonists API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROKININ RECEPTOR ANTAGONISTS API BY GEOGRAPHIC REGION
4.1 World Historic Neurokinin Receptor Antagonists API Market Size by Geographic Region (2021-2026)
4.1.1 Global Neurokinin Receptor Antagonists API Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Neurokinin Receptor Antagonists API Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Neurokinin Receptor Antagonists API Market Size by Country/Region (2021-2026)
4.2.1 Global Neurokinin Receptor Antagonists API Annual Sales by Country/Region (2021-2026)
4.2.2 Global Neurokinin Receptor Antagonists API Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neurokinin Receptor Antagonists API Sales Growth
4.4 APAC Neurokinin Receptor Antagonists API Sales Growth
4.5 Europe Neurokinin Receptor Antagonists API Sales Growth
4.6 Middle East & Africa Neurokinin Receptor Antagonists API Sales Growth
5 AMERICAS
5.1 Americas Neurokinin Receptor Antagonists API Sales by Country
5.1.1 Americas Neurokinin Receptor Antagonists API Sales by Country (2021-2026)
5.1.2 Americas Neurokinin Receptor Antagonists API Revenue by Country (2021-2026)
5.2 Americas Neurokinin Receptor Antagonists API Sales by Type (2021-2026)
5.3 Americas Neurokinin Receptor Antagonists API Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurokinin Receptor Antagonists API Sales by Region
6.1.1 APAC Neurokinin Receptor Antagonists API Sales by Region (2021-2026)
6.1.2 APAC Neurokinin Receptor Antagonists API Revenue by Region (2021-2026)
6.2 APAC Neurokinin Receptor Antagonists API Sales by Type (2021-2026)
6.3 APAC Neurokinin Receptor Antagonists API Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurokinin Receptor Antagonists API by Country
7.1.1 Europe Neurokinin Receptor Antagonists API Sales by Country (2021-2026)
7.1.2 Europe Neurokinin Receptor Antagonists API Revenue by Country (2021-2026)
7.2 Europe Neurokinin Receptor Antagonists API Sales by Type (2021-2026)
7.3 Europe Neurokinin Receptor Antagonists API Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurokinin Receptor Antagonists API by Country
8.1.1 Middle East & Africa Neurokinin Receptor Antagonists API Sales by Country (2021-2026)
8.1.2 Middle East & Africa Neurokinin Receptor Antagonists API Revenue by Country (2021-2026)
8.2 Middle East & Africa Neurokinin Receptor Antagonists API Sales by Type (2021-2026)
8.3 Middle East & Africa Neurokinin Receptor Antagonists API Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurokinin Receptor Antagonists API
10.3 Manufacturing Process Analysis of Neurokinin Receptor Antagonists API
10.4 Industry Chain Structure of Neurokinin Receptor Antagonists API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurokinin Receptor Antagonists API Distributors
11.3 Neurokinin Receptor Antagonists API Customer
12 WORLD FORECAST REVIEW FOR NEUROKININ RECEPTOR ANTAGONISTS API BY GEOGRAPHIC REGION
12.1 Global Neurokinin Receptor Antagonists API Market Size Forecast by Region
12.1.1 Global Neurokinin Receptor Antagonists API Forecast by Region (2027-2032)
12.1.2 Global Neurokinin Receptor Antagonists API Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Neurokinin Receptor Antagonists API Forecast by Type (2027-2032)
12.7 Global Neurokinin Receptor Antagonists API Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Dr. Reddy's Laboratories
13.1.1 Dr. Reddy's Laboratories Company Information
13.1.2 Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.1.3 Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Dr. Reddy's Laboratories Main Business Overview
13.1.5 Dr. Reddy's Laboratories Latest Developments
13.2 Glenmark Life Sciences
13.2.1 Glenmark Life Sciences Company Information
13.2.2 Glenmark Life Sciences Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.2.3 Glenmark Life Sciences Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Glenmark Life Sciences Main Business Overview
13.2.5 Glenmark Life Sciences Latest Developments
13.3 Jubilant Pharmova
13.3.1 Jubilant Pharmova Company Information
13.3.2 Jubilant Pharmova Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.3.3 Jubilant Pharmova Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Jubilant Pharmova Main Business Overview
13.3.5 Jubilant Pharmova Latest Developments
13.4 Murli Krishna Pharma
13.4.1 Murli Krishna Pharma Company Information
13.4.2 Murli Krishna Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.4.3 Murli Krishna Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Murli Krishna Pharma Main Business Overview
13.4.5 Murli Krishna Pharma Latest Developments
13.5 MSN Laboratories
13.5.1 MSN Laboratories Company Information
13.5.2 MSN Laboratories Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.5.3 MSN Laboratories Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 MSN Laboratories Main Business Overview
13.5.5 MSN Laboratories Latest Developments
13.6 Optimus Pharma
13.6.1 Optimus Pharma Company Information
13.6.2 Optimus Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.6.3 Optimus Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Optimus Pharma Main Business Overview
13.6.5 Optimus Pharma Latest Developments
13.7 Piramal Pharma
13.7.1 Piramal Pharma Company Information
13.7.2 Piramal Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.7.3 Piramal Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Piramal Pharma Main Business Overview
13.7.5 Piramal Pharma Latest Developments
13.8 Solara Active Pharma Sciences
13.8.1 Solara Active Pharma Sciences Company Information
13.8.2 Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.8.3 Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Solara Active Pharma Sciences Main Business Overview
13.8.5 Solara Active Pharma Sciences Latest Developments
13.9 Camus Pharma
13.9.1 Camus Pharma Company Information
13.9.2 Camus Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.9.3 Camus Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Camus Pharma Main Business Overview
13.9.5 Camus Pharma Latest Developments
13.10 Clearsynth Labs
13.10.1 Clearsynth Labs Company Information
13.10.2 Clearsynth Labs Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.10.3 Clearsynth Labs Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Clearsynth Labs Main Business Overview
13.10.5 Clearsynth Labs Latest Developments
13.11 Helsinn Advanced Synthesis
13.11.1 Helsinn Advanced Synthesis Company Information
13.11.2 Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.11.3 Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Helsinn Advanced Synthesis Main Business Overview
13.11.5 Helsinn Advanced Synthesis Latest Developments
13.12 Procos
13.12.1 Procos Company Information
13.12.2 Procos Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.12.3 Procos Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Procos Main Business Overview
13.12.5 Procos Latest Developments
13.13 Andenex
13.13.1 Andenex Company Information
13.13.2 Andenex Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.13.3 Andenex Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Andenex Main Business Overview
13.13.5 Andenex Latest Developments
13.14 Taizhou Crene Biotechnology
13.14.1 Taizhou Crene Biotechnology Company Information
13.14.2 Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.14.3 Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Taizhou Crene Biotechnology Main Business Overview
13.14.5 Taizhou Crene Biotechnology Latest Developments
13.15 Zydus Animal Health And Investments
13.15.1 Zydus Animal Health And Investments Company Information
13.15.2 Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.15.3 Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Zydus Animal Health And Investments Main Business Overview
13.15.5 Zydus Animal Health And Investments Latest Developments
13.16 Wisdom Pharmaceutical
13.16.1 Wisdom Pharmaceutical Company Information
13.16.2 Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.16.3 Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Wisdom Pharmaceutical Main Business Overview
13.16.5 Wisdom Pharmaceutical Latest Developments
13.17 Zhejiang Tiantai Pharmaceutical
13.17.1 Zhejiang Tiantai Pharmaceutical Company Information
13.17.2 Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.17.3 Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Zhejiang Tiantai Pharmaceutical Main Business Overview
13.17.5 Zhejiang Tiantai Pharmaceutical Latest Developments
13.18 Qilu Pharmaceutical
13.18.1 Qilu Pharmaceutical Company Information
13.18.2 Qilu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.18.3 Qilu Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Qilu Pharmaceutical Main Business Overview
13.18.5 Qilu Pharmaceutical Latest Developments
13.19 Kelun Pharmaceutical
13.19.1 Kelun Pharmaceutical Company Information
13.19.2 Kelun Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.19.3 Kelun Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Kelun Pharmaceutical Main Business Overview
13.19.5 Kelun Pharmaceutical Latest Developments
13.20 Hansoh Pharma
13.20.1 Hansoh Pharma Company Information
13.20.2 Hansoh Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.20.3 Hansoh Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Hansoh Pharma Main Business Overview
13.20.5 Hansoh Pharma Latest Developments
13.21 Luoxin Pharmaceuticals
13.21.1 Luoxin Pharmaceuticals Company Information
13.21.2 Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.21.3 Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Luoxin Pharmaceuticals Main Business Overview
13.21.5 Luoxin Pharmaceuticals Latest Developments
13.22 Hangzhou Jiuyuan Gene Engineering
13.22.1 Hangzhou Jiuyuan Gene Engineering Company Information
13.22.2 Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.22.3 Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Hangzhou Jiuyuan Gene Engineering Main Business Overview
13.22.5 Hangzhou Jiuyuan Gene Engineering Latest Developments
13.23 Lianyungang Runzhong Pharmaceutical
13.23.1 Lianyungang Runzhong Pharmaceutical Company Information
13.23.2 Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.23.3 Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Lianyungang Runzhong Pharmaceutical Main Business Overview
13.23.5 Lianyungang Runzhong Pharmaceutical Latest Developments
13.24 Viwit
13.24.1 Viwit Company Information
13.24.2 Viwit Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.24.3 Viwit Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Viwit Main Business Overview
13.24.5 Viwit Latest Developments
13.25 Humanwell Pharmaceutical
13.25.1 Humanwell Pharmaceutical Company Information
13.25.2 Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.25.3 Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Humanwell Pharmaceutical Main Business Overview
13.25.5 Humanwell Pharmaceutical Latest Developments
13.26 Shandong Anxin Pharmaceutical
13.26.1 Shandong Anxin Pharmaceutical Company Information
13.26.2 Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.26.3 Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Shandong Anxin Pharmaceutical Main Business Overview
13.26.5 Shandong Anxin Pharmaceutical Latest Developments
13.27 Beijing Sjar Technology Development
13.27.1 Beijing Sjar Technology Development Company Information
13.27.2 Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.27.3 Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Beijing Sjar Technology Development Main Business Overview
13.27.5 Beijing Sjar Technology Development Latest Developments
13.28 Sichuan Qingmu Pharmaceutical
13.28.1 Sichuan Qingmu Pharmaceutical Company Information
13.28.2 Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.28.3 Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Sichuan Qingmu Pharmaceutical Main Business Overview
13.28.5 Sichuan Qingmu Pharmaceutical Latest Developments
13.29 Shandong New Time Pharmaceutical
13.29.1 Shandong New Time Pharmaceutical Company Information
13.29.2 Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.29.3 Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.29.4 Shandong New Time Pharmaceutical Main Business Overview
13.29.5 Shandong New Time Pharmaceutical Latest Developments
13.30 United Pharma
13.30.1 United Pharma Company Information
13.30.2 United Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.30.3 United Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.30.4 United Pharma Main Business Overview
13.30.5 United Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurokinin Receptor Antagonists API Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Neurokinin Receptor Antagonists API by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Neurokinin Receptor Antagonists API by Country/Region, 2021, 2025 & 2032
2.2 Neurokinin Receptor Antagonists API Segment by Type
2.2.1 Fezolinetant
2.2.2 Aprepitant
2.2.3 Rolapitant
2.2.4 Fosaprepitant
2.2.5 Netupitant
2.2.6 Maropitant
2.2.7 Neurokinin Receptor Antagonists API Sales by Type
2.2.7.1 Global Neurokinin Receptor Antagonists API Sales Market Share by Type (2021-2026)
2.2.7.2 Global Neurokinin Receptor Antagonists API Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Neurokinin Receptor Antagonists API Sale Price by Type (2021-2026)
2.3 Neurokinin Receptor Antagonists API Segment by Application
2.3.1 Tablets
2.3.2 Capsules
2.3.3 Oral Suspension
2.3.4 Injections
2.3.5 Other
2.3.6 Neurokinin Receptor Antagonists API Sales by Application
2.3.6.1 Global Neurokinin Receptor Antagonists API Sale Market Share by Application (2021-2026)
2.3.6.2 Global Neurokinin Receptor Antagonists API Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Neurokinin Receptor Antagonists API Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Neurokinin Receptor Antagonists API Breakdown Data by Company
3.1.1 Global Neurokinin Receptor Antagonists API Annual Sales by Company (2021-2026)
3.1.2 Global Neurokinin Receptor Antagonists API Sales Market Share by Company (2021-2026)
3.2 Global Neurokinin Receptor Antagonists API Annual Revenue by Company (2021-2026)
3.2.1 Global Neurokinin Receptor Antagonists API Revenue by Company (2021-2026)
3.2.2 Global Neurokinin Receptor Antagonists API Revenue Market Share by Company (2021-2026)
3.3 Global Neurokinin Receptor Antagonists API Sale Price by Company
3.4 Key Manufacturers Neurokinin Receptor Antagonists API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurokinin Receptor Antagonists API Product Location Distribution
3.4.2 Players Neurokinin Receptor Antagonists API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROKININ RECEPTOR ANTAGONISTS API BY GEOGRAPHIC REGION
4.1 World Historic Neurokinin Receptor Antagonists API Market Size by Geographic Region (2021-2026)
4.1.1 Global Neurokinin Receptor Antagonists API Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Neurokinin Receptor Antagonists API Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Neurokinin Receptor Antagonists API Market Size by Country/Region (2021-2026)
4.2.1 Global Neurokinin Receptor Antagonists API Annual Sales by Country/Region (2021-2026)
4.2.2 Global Neurokinin Receptor Antagonists API Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neurokinin Receptor Antagonists API Sales Growth
4.4 APAC Neurokinin Receptor Antagonists API Sales Growth
4.5 Europe Neurokinin Receptor Antagonists API Sales Growth
4.6 Middle East & Africa Neurokinin Receptor Antagonists API Sales Growth
5 AMERICAS
5.1 Americas Neurokinin Receptor Antagonists API Sales by Country
5.1.1 Americas Neurokinin Receptor Antagonists API Sales by Country (2021-2026)
5.1.2 Americas Neurokinin Receptor Antagonists API Revenue by Country (2021-2026)
5.2 Americas Neurokinin Receptor Antagonists API Sales by Type (2021-2026)
5.3 Americas Neurokinin Receptor Antagonists API Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurokinin Receptor Antagonists API Sales by Region
6.1.1 APAC Neurokinin Receptor Antagonists API Sales by Region (2021-2026)
6.1.2 APAC Neurokinin Receptor Antagonists API Revenue by Region (2021-2026)
6.2 APAC Neurokinin Receptor Antagonists API Sales by Type (2021-2026)
6.3 APAC Neurokinin Receptor Antagonists API Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurokinin Receptor Antagonists API by Country
7.1.1 Europe Neurokinin Receptor Antagonists API Sales by Country (2021-2026)
7.1.2 Europe Neurokinin Receptor Antagonists API Revenue by Country (2021-2026)
7.2 Europe Neurokinin Receptor Antagonists API Sales by Type (2021-2026)
7.3 Europe Neurokinin Receptor Antagonists API Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurokinin Receptor Antagonists API by Country
8.1.1 Middle East & Africa Neurokinin Receptor Antagonists API Sales by Country (2021-2026)
8.1.2 Middle East & Africa Neurokinin Receptor Antagonists API Revenue by Country (2021-2026)
8.2 Middle East & Africa Neurokinin Receptor Antagonists API Sales by Type (2021-2026)
8.3 Middle East & Africa Neurokinin Receptor Antagonists API Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurokinin Receptor Antagonists API
10.3 Manufacturing Process Analysis of Neurokinin Receptor Antagonists API
10.4 Industry Chain Structure of Neurokinin Receptor Antagonists API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurokinin Receptor Antagonists API Distributors
11.3 Neurokinin Receptor Antagonists API Customer
12 WORLD FORECAST REVIEW FOR NEUROKININ RECEPTOR ANTAGONISTS API BY GEOGRAPHIC REGION
12.1 Global Neurokinin Receptor Antagonists API Market Size Forecast by Region
12.1.1 Global Neurokinin Receptor Antagonists API Forecast by Region (2027-2032)
12.1.2 Global Neurokinin Receptor Antagonists API Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Neurokinin Receptor Antagonists API Forecast by Type (2027-2032)
12.7 Global Neurokinin Receptor Antagonists API Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Dr. Reddy's Laboratories
13.1.1 Dr. Reddy's Laboratories Company Information
13.1.2 Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.1.3 Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Dr. Reddy's Laboratories Main Business Overview
13.1.5 Dr. Reddy's Laboratories Latest Developments
13.2 Glenmark Life Sciences
13.2.1 Glenmark Life Sciences Company Information
13.2.2 Glenmark Life Sciences Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.2.3 Glenmark Life Sciences Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Glenmark Life Sciences Main Business Overview
13.2.5 Glenmark Life Sciences Latest Developments
13.3 Jubilant Pharmova
13.3.1 Jubilant Pharmova Company Information
13.3.2 Jubilant Pharmova Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.3.3 Jubilant Pharmova Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Jubilant Pharmova Main Business Overview
13.3.5 Jubilant Pharmova Latest Developments
13.4 Murli Krishna Pharma
13.4.1 Murli Krishna Pharma Company Information
13.4.2 Murli Krishna Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.4.3 Murli Krishna Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Murli Krishna Pharma Main Business Overview
13.4.5 Murli Krishna Pharma Latest Developments
13.5 MSN Laboratories
13.5.1 MSN Laboratories Company Information
13.5.2 MSN Laboratories Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.5.3 MSN Laboratories Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 MSN Laboratories Main Business Overview
13.5.5 MSN Laboratories Latest Developments
13.6 Optimus Pharma
13.6.1 Optimus Pharma Company Information
13.6.2 Optimus Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.6.3 Optimus Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Optimus Pharma Main Business Overview
13.6.5 Optimus Pharma Latest Developments
13.7 Piramal Pharma
13.7.1 Piramal Pharma Company Information
13.7.2 Piramal Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.7.3 Piramal Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Piramal Pharma Main Business Overview
13.7.5 Piramal Pharma Latest Developments
13.8 Solara Active Pharma Sciences
13.8.1 Solara Active Pharma Sciences Company Information
13.8.2 Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.8.3 Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Solara Active Pharma Sciences Main Business Overview
13.8.5 Solara Active Pharma Sciences Latest Developments
13.9 Camus Pharma
13.9.1 Camus Pharma Company Information
13.9.2 Camus Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.9.3 Camus Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Camus Pharma Main Business Overview
13.9.5 Camus Pharma Latest Developments
13.10 Clearsynth Labs
13.10.1 Clearsynth Labs Company Information
13.10.2 Clearsynth Labs Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.10.3 Clearsynth Labs Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Clearsynth Labs Main Business Overview
13.10.5 Clearsynth Labs Latest Developments
13.11 Helsinn Advanced Synthesis
13.11.1 Helsinn Advanced Synthesis Company Information
13.11.2 Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.11.3 Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Helsinn Advanced Synthesis Main Business Overview
13.11.5 Helsinn Advanced Synthesis Latest Developments
13.12 Procos
13.12.1 Procos Company Information
13.12.2 Procos Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.12.3 Procos Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Procos Main Business Overview
13.12.5 Procos Latest Developments
13.13 Andenex
13.13.1 Andenex Company Information
13.13.2 Andenex Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.13.3 Andenex Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Andenex Main Business Overview
13.13.5 Andenex Latest Developments
13.14 Taizhou Crene Biotechnology
13.14.1 Taizhou Crene Biotechnology Company Information
13.14.2 Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.14.3 Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Taizhou Crene Biotechnology Main Business Overview
13.14.5 Taizhou Crene Biotechnology Latest Developments
13.15 Zydus Animal Health And Investments
13.15.1 Zydus Animal Health And Investments Company Information
13.15.2 Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.15.3 Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Zydus Animal Health And Investments Main Business Overview
13.15.5 Zydus Animal Health And Investments Latest Developments
13.16 Wisdom Pharmaceutical
13.16.1 Wisdom Pharmaceutical Company Information
13.16.2 Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.16.3 Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Wisdom Pharmaceutical Main Business Overview
13.16.5 Wisdom Pharmaceutical Latest Developments
13.17 Zhejiang Tiantai Pharmaceutical
13.17.1 Zhejiang Tiantai Pharmaceutical Company Information
13.17.2 Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.17.3 Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Zhejiang Tiantai Pharmaceutical Main Business Overview
13.17.5 Zhejiang Tiantai Pharmaceutical Latest Developments
13.18 Qilu Pharmaceutical
13.18.1 Qilu Pharmaceutical Company Information
13.18.2 Qilu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.18.3 Qilu Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Qilu Pharmaceutical Main Business Overview
13.18.5 Qilu Pharmaceutical Latest Developments
13.19 Kelun Pharmaceutical
13.19.1 Kelun Pharmaceutical Company Information
13.19.2 Kelun Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.19.3 Kelun Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Kelun Pharmaceutical Main Business Overview
13.19.5 Kelun Pharmaceutical Latest Developments
13.20 Hansoh Pharma
13.20.1 Hansoh Pharma Company Information
13.20.2 Hansoh Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.20.3 Hansoh Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Hansoh Pharma Main Business Overview
13.20.5 Hansoh Pharma Latest Developments
13.21 Luoxin Pharmaceuticals
13.21.1 Luoxin Pharmaceuticals Company Information
13.21.2 Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.21.3 Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Luoxin Pharmaceuticals Main Business Overview
13.21.5 Luoxin Pharmaceuticals Latest Developments
13.22 Hangzhou Jiuyuan Gene Engineering
13.22.1 Hangzhou Jiuyuan Gene Engineering Company Information
13.22.2 Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.22.3 Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Hangzhou Jiuyuan Gene Engineering Main Business Overview
13.22.5 Hangzhou Jiuyuan Gene Engineering Latest Developments
13.23 Lianyungang Runzhong Pharmaceutical
13.23.1 Lianyungang Runzhong Pharmaceutical Company Information
13.23.2 Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.23.3 Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Lianyungang Runzhong Pharmaceutical Main Business Overview
13.23.5 Lianyungang Runzhong Pharmaceutical Latest Developments
13.24 Viwit
13.24.1 Viwit Company Information
13.24.2 Viwit Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.24.3 Viwit Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Viwit Main Business Overview
13.24.5 Viwit Latest Developments
13.25 Humanwell Pharmaceutical
13.25.1 Humanwell Pharmaceutical Company Information
13.25.2 Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.25.3 Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Humanwell Pharmaceutical Main Business Overview
13.25.5 Humanwell Pharmaceutical Latest Developments
13.26 Shandong Anxin Pharmaceutical
13.26.1 Shandong Anxin Pharmaceutical Company Information
13.26.2 Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.26.3 Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Shandong Anxin Pharmaceutical Main Business Overview
13.26.5 Shandong Anxin Pharmaceutical Latest Developments
13.27 Beijing Sjar Technology Development
13.27.1 Beijing Sjar Technology Development Company Information
13.27.2 Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.27.3 Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Beijing Sjar Technology Development Main Business Overview
13.27.5 Beijing Sjar Technology Development Latest Developments
13.28 Sichuan Qingmu Pharmaceutical
13.28.1 Sichuan Qingmu Pharmaceutical Company Information
13.28.2 Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.28.3 Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Sichuan Qingmu Pharmaceutical Main Business Overview
13.28.5 Sichuan Qingmu Pharmaceutical Latest Developments
13.29 Shandong New Time Pharmaceutical
13.29.1 Shandong New Time Pharmaceutical Company Information
13.29.2 Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.29.3 Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.29.4 Shandong New Time Pharmaceutical Main Business Overview
13.29.5 Shandong New Time Pharmaceutical Latest Developments
13.30 United Pharma
13.30.1 United Pharma Company Information
13.30.2 United Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
13.30.3 United Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
13.30.4 United Pharma Main Business Overview
13.30.5 United Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurokinin Receptor Antagonists API Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Neurokinin Receptor Antagonists API Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fezolinetant
Table 4. Major Players of Aprepitant
Table 5. Major Players of Rolapitant
Table 6. Major Players of Fosaprepitant
Table 7. Major Players of Netupitant
Table 8. Major Players of Maropitant
Table 9. Global Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons)
Table 10. Global Neurokinin Receptor Antagonists API Sales Market Share by Type (2021-2026)
Table 11. Global Neurokinin Receptor Antagonists API Revenue by Type (2021-2026) & ($ million)
Table 12. Global Neurokinin Receptor Antagonists API Revenue Market Share by Type (2021-2026)
Table 13. Global Neurokinin Receptor Antagonists API Sale Price by Type (2021-2026) & (US$/kg)
Table 14. Global Neurokinin Receptor Antagonists API Sale by Application (2021-2026) & (Tons)
Table 15. Global Neurokinin Receptor Antagonists API Sale Market Share by Application (2021-2026)
Table 16. Global Neurokinin Receptor Antagonists API Revenue by Application (2021-2026) & ($ million)
Table 17. Global Neurokinin Receptor Antagonists API Revenue Market Share by Application (2021-2026)
Table 18. Global Neurokinin Receptor Antagonists API Sale Price by Application (2021-2026) & (US$/kg)
Table 19. Global Neurokinin Receptor Antagonists API Sales by Company (2021-2026) & (Tons)
Table 20. Global Neurokinin Receptor Antagonists API Sales Market Share by Company (2021-2026)
Table 21. Global Neurokinin Receptor Antagonists API Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Neurokinin Receptor Antagonists API Revenue Market Share by Company (2021-2026)
Table 23. Global Neurokinin Receptor Antagonists API Sale Price by Company (2021-2026) & (US$/kg)
Table 24. Key Manufacturers Neurokinin Receptor Antagonists API Producing Area Distribution and Sales Area
Table 25. Players Neurokinin Receptor Antagonists API Products Offered
Table 26. Neurokinin Receptor Antagonists API Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Neurokinin Receptor Antagonists API Sales by Geographic Region (2021-2026) & (Tons)
Table 30. Global Neurokinin Receptor Antagonists API Sales Market Share Geographic Region (2021-2026)
Table 31. Global Neurokinin Receptor Antagonists API Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Neurokinin Receptor Antagonists API Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Neurokinin Receptor Antagonists API Sales by Country/Region (2021-2026) & (Tons)
Table 34. Global Neurokinin Receptor Antagonists API Sales Market Share by Country/Region (2021-2026)
Table 35. Global Neurokinin Receptor Antagonists API Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Neurokinin Receptor Antagonists API Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons)
Table 38. Americas Neurokinin Receptor Antagonists API Sales Market Share by Country (2021-2026)
Table 39. Americas Neurokinin Receptor Antagonists API Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons)
Table 41. Americas Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons)
Table 42. APAC Neurokinin Receptor Antagonists API Sales by Region (2021-2026) & (Tons)
Table 43. APAC Neurokinin Receptor Antagonists API Sales Market Share by Region (2021-2026)
Table 44. APAC Neurokinin Receptor Antagonists API Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons)
Table 46. APAC Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons)
Table 47. Europe Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons)
Table 48. Europe Neurokinin Receptor Antagonists API Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons)
Table 50. Europe Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons)
Table 51. Middle East & Africa Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons)
Table 52. Middle East & Africa Neurokinin Receptor Antagonists API Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons)
Table 54. Middle East & Africa Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons)
Table 55. Key Market Drivers & Growth Opportunities of Neurokinin Receptor Antagonists API
Table 56. Key Market Challenges & Risks of Neurokinin Receptor Antagonists API
Table 57. Key Industry Trends of Neurokinin Receptor Antagonists API
Table 58. Neurokinin Receptor Antagonists API Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Neurokinin Receptor Antagonists API Distributors List
Table 61. Neurokinin Receptor Antagonists API Customer List
Table 62. Global Neurokinin Receptor Antagonists API Sales Forecast by Region (2027-2032) & (Tons)
Table 63. Global Neurokinin Receptor Antagonists API Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032) & (Tons)
Table 65. Americas Neurokinin Receptor Antagonists API Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Neurokinin Receptor Antagonists API Sales Forecast by Region (2027-2032) & (Tons)
Table 67. APAC Neurokinin Receptor Antagonists API Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032) & (Tons)
Table 69. Europe Neurokinin Receptor Antagonists API Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032) & (Tons)
Table 71. Middle East & Africa Neurokinin Receptor Antagonists API Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Neurokinin Receptor Antagonists API Sales Forecast by Type (2027-2032) & (Tons)
Table 73. Global Neurokinin Receptor Antagonists API Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Neurokinin Receptor Antagonists API Sales Forecast by Application (2027-2032) & (Tons)
Table 75. Global Neurokinin Receptor Antagonists API Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. Dr. Reddy's Laboratories Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 77. Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 78. Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 79. Dr. Reddy's Laboratories Main Business
Table 80. Dr. Reddy's Laboratories Latest Developments
Table 81. Glenmark Life Sciences Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 82. Glenmark Life Sciences Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 83. Glenmark Life Sciences Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 84. Glenmark Life Sciences Main Business
Table 85. Glenmark Life Sciences Latest Developments
Table 86. Jubilant Pharmova Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 87. Jubilant Pharmova Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 88. Jubilant Pharmova Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 89. Jubilant Pharmova Main Business
Table 90. Jubilant Pharmova Latest Developments
Table 91. Murli Krishna Pharma Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 92. Murli Krishna Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 93. Murli Krishna Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 94. Murli Krishna Pharma Main Business
Table 95. Murli Krishna Pharma Latest Developments
Table 96. MSN Laboratories Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 97. MSN Laboratories Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 98. MSN Laboratories Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 99. MSN Laboratories Main Business
Table 100. MSN Laboratories Latest Developments
Table 101. Optimus Pharma Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 102. Optimus Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 103. Optimus Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 104. Optimus Pharma Main Business
Table 105. Optimus Pharma Latest Developments
Table 106. Piramal Pharma Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 107. Piramal Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 108. Piramal Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 109. Piramal Pharma Main Business
Table 110. Piramal Pharma Latest Developments
Table 111. Solara Active Pharma Sciences Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 112. Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 113. Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 114. Solara Active Pharma Sciences Main Business
Table 115. Solara Active Pharma Sciences Latest Developments
Table 116. Camus Pharma Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 117. Camus Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 118. Camus Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 119. Camus Pharma Main Business
Table 120. Camus Pharma Latest Developments
Table 121. Clearsynth Labs Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 122. Clearsynth Labs Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 123. Clearsynth Labs Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 124. Clearsynth Labs Main Business
Table 125. Clearsynth Labs Latest Developments
Table 126. Helsinn Advanced Synthesis Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 127. Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 128. Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 129. Helsinn Advanced Synthesis Main Business
Table 130. Helsinn Advanced Synthesis Latest Developments
Table 131. Procos Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 132. Procos Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 133. Procos Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 134. Procos Main Business
Table 135. Procos Latest Developments
Table 136. Andenex Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 137. Andenex Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 138. Andenex Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 139. Andenex Main Business
Table 140. Andenex Latest Developments
Table 141. Taizhou Crene Biotechnology Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 142. Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 143. Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 144. Taizhou Crene Biotechnology Main Business
Table 145. Taizhou Crene Biotechnology Latest Developments
Table 146. Zydus Animal Health And Investments Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 147. Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 148. Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 149. Zydus Animal Health And Investments Main Business
Table 150. Zydus Animal Health And Investments Latest Developments
Table 151. Wisdom Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 152. Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 153. Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 154. Wisdom Pharmaceutical Main Business
Table 155. Wisdom Pharmaceutical Latest Developments
Table 156. Zhejiang Tiantai Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 157. Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 158. Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 159. Zhejiang Tiantai Pharmaceutical Main Business
Table 160. Zhejiang Tiantai Pharmaceutical Latest Developments
Table 161. Qilu Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 162. Qilu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 163. Qilu Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 164. Qilu Pharmaceutical Main Business
Table 165. Qilu Pharmaceutical Latest Developments
Table 166. Kelun Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 167. Kelun Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 168. Kelun Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 169. Kelun Pharmaceutical Main Business
Table 170. Kelun Pharmaceutical Latest Developments
Table 171. Hansoh Pharma Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 172. Hansoh Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 173. Hansoh Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 174. Hansoh Pharma Main Business
Table 175. Hansoh Pharma Latest Developments
Table 176. Luoxin Pharmaceuticals Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 177. Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 178. Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 179. Luoxin Pharmaceuticals Main Business
Table 180. Luoxin Pharmaceuticals Latest Developments
Table 181. Hangzhou Jiuyuan Gene Engineering Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 182. Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 183. Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 184. Hangzhou Jiuyuan Gene Engineering Main Business
Table 185. Hangzhou Jiuyuan Gene Engineering Latest Developments
Table 186. Lianyungang Runzhong Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 187. Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 188. Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 189. Lianyungang Runzhong Pharmaceutical Main Business
Table 190. Lianyungang Runzhong Pharmaceutical Latest Developments
Table 191. Viwit Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 192. Viwit Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 193. Viwit Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 194. Viwit Main Business
Table 195. Viwit Latest Developments
Table 196. Humanwell Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 197. Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 198. Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 199. Humanwell Pharmaceutical Main Business
Table 200. Humanwell Pharmaceutical Latest Developments
Table 201. Shandong Anxin Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 202. Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 203. Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 204. Shandong Anxin Pharmaceutical Main Business
Table 205. Shandong Anxin Pharmaceutical Latest Developments
Table 206. Beijing Sjar Technology Development Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 207. Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 208. Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 209. Beijing Sjar Technology Development Main Business
Table 210. Beijing Sjar Technology Development Latest Developments
Table 211. Sichuan Qingmu Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 212. Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 213. Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 214. Sichuan Qingmu Pharmaceutical Main Business
Table 215. Sichuan Qingmu Pharmaceutical Latest Developments
Table 216. Shandong New Time Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 217. Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 218. Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 219. Shandong New Time Pharmaceutical Main Business
Table 220. Shandong New Time Pharmaceutical Latest Developments
Table 221. United Pharma Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 222. United Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 223. United Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 224. United Pharma Main Business
Table 225. United Pharma Latest Developments
Table 1. Neurokinin Receptor Antagonists API Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Neurokinin Receptor Antagonists API Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fezolinetant
Table 4. Major Players of Aprepitant
Table 5. Major Players of Rolapitant
Table 6. Major Players of Fosaprepitant
Table 7. Major Players of Netupitant
Table 8. Major Players of Maropitant
Table 9. Global Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons)
Table 10. Global Neurokinin Receptor Antagonists API Sales Market Share by Type (2021-2026)
Table 11. Global Neurokinin Receptor Antagonists API Revenue by Type (2021-2026) & ($ million)
Table 12. Global Neurokinin Receptor Antagonists API Revenue Market Share by Type (2021-2026)
Table 13. Global Neurokinin Receptor Antagonists API Sale Price by Type (2021-2026) & (US$/kg)
Table 14. Global Neurokinin Receptor Antagonists API Sale by Application (2021-2026) & (Tons)
Table 15. Global Neurokinin Receptor Antagonists API Sale Market Share by Application (2021-2026)
Table 16. Global Neurokinin Receptor Antagonists API Revenue by Application (2021-2026) & ($ million)
Table 17. Global Neurokinin Receptor Antagonists API Revenue Market Share by Application (2021-2026)
Table 18. Global Neurokinin Receptor Antagonists API Sale Price by Application (2021-2026) & (US$/kg)
Table 19. Global Neurokinin Receptor Antagonists API Sales by Company (2021-2026) & (Tons)
Table 20. Global Neurokinin Receptor Antagonists API Sales Market Share by Company (2021-2026)
Table 21. Global Neurokinin Receptor Antagonists API Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Neurokinin Receptor Antagonists API Revenue Market Share by Company (2021-2026)
Table 23. Global Neurokinin Receptor Antagonists API Sale Price by Company (2021-2026) & (US$/kg)
Table 24. Key Manufacturers Neurokinin Receptor Antagonists API Producing Area Distribution and Sales Area
Table 25. Players Neurokinin Receptor Antagonists API Products Offered
Table 26. Neurokinin Receptor Antagonists API Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Neurokinin Receptor Antagonists API Sales by Geographic Region (2021-2026) & (Tons)
Table 30. Global Neurokinin Receptor Antagonists API Sales Market Share Geographic Region (2021-2026)
Table 31. Global Neurokinin Receptor Antagonists API Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Neurokinin Receptor Antagonists API Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Neurokinin Receptor Antagonists API Sales by Country/Region (2021-2026) & (Tons)
Table 34. Global Neurokinin Receptor Antagonists API Sales Market Share by Country/Region (2021-2026)
Table 35. Global Neurokinin Receptor Antagonists API Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Neurokinin Receptor Antagonists API Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons)
Table 38. Americas Neurokinin Receptor Antagonists API Sales Market Share by Country (2021-2026)
Table 39. Americas Neurokinin Receptor Antagonists API Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons)
Table 41. Americas Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons)
Table 42. APAC Neurokinin Receptor Antagonists API Sales by Region (2021-2026) & (Tons)
Table 43. APAC Neurokinin Receptor Antagonists API Sales Market Share by Region (2021-2026)
Table 44. APAC Neurokinin Receptor Antagonists API Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons)
Table 46. APAC Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons)
Table 47. Europe Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons)
Table 48. Europe Neurokinin Receptor Antagonists API Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons)
Table 50. Europe Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons)
Table 51. Middle East & Africa Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons)
Table 52. Middle East & Africa Neurokinin Receptor Antagonists API Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons)
Table 54. Middle East & Africa Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons)
Table 55. Key Market Drivers & Growth Opportunities of Neurokinin Receptor Antagonists API
Table 56. Key Market Challenges & Risks of Neurokinin Receptor Antagonists API
Table 57. Key Industry Trends of Neurokinin Receptor Antagonists API
Table 58. Neurokinin Receptor Antagonists API Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Neurokinin Receptor Antagonists API Distributors List
Table 61. Neurokinin Receptor Antagonists API Customer List
Table 62. Global Neurokinin Receptor Antagonists API Sales Forecast by Region (2027-2032) & (Tons)
Table 63. Global Neurokinin Receptor Antagonists API Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032) & (Tons)
Table 65. Americas Neurokinin Receptor Antagonists API Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Neurokinin Receptor Antagonists API Sales Forecast by Region (2027-2032) & (Tons)
Table 67. APAC Neurokinin Receptor Antagonists API Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032) & (Tons)
Table 69. Europe Neurokinin Receptor Antagonists API Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Neurokinin Receptor Antagonists API Sales Forecast by Country (2027-2032) & (Tons)
Table 71. Middle East & Africa Neurokinin Receptor Antagonists API Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Neurokinin Receptor Antagonists API Sales Forecast by Type (2027-2032) & (Tons)
Table 73. Global Neurokinin Receptor Antagonists API Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Neurokinin Receptor Antagonists API Sales Forecast by Application (2027-2032) & (Tons)
Table 75. Global Neurokinin Receptor Antagonists API Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. Dr. Reddy's Laboratories Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 77. Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 78. Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 79. Dr. Reddy's Laboratories Main Business
Table 80. Dr. Reddy's Laboratories Latest Developments
Table 81. Glenmark Life Sciences Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 82. Glenmark Life Sciences Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 83. Glenmark Life Sciences Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 84. Glenmark Life Sciences Main Business
Table 85. Glenmark Life Sciences Latest Developments
Table 86. Jubilant Pharmova Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 87. Jubilant Pharmova Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 88. Jubilant Pharmova Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 89. Jubilant Pharmova Main Business
Table 90. Jubilant Pharmova Latest Developments
Table 91. Murli Krishna Pharma Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 92. Murli Krishna Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 93. Murli Krishna Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 94. Murli Krishna Pharma Main Business
Table 95. Murli Krishna Pharma Latest Developments
Table 96. MSN Laboratories Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 97. MSN Laboratories Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 98. MSN Laboratories Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 99. MSN Laboratories Main Business
Table 100. MSN Laboratories Latest Developments
Table 101. Optimus Pharma Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 102. Optimus Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 103. Optimus Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 104. Optimus Pharma Main Business
Table 105. Optimus Pharma Latest Developments
Table 106. Piramal Pharma Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 107. Piramal Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 108. Piramal Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 109. Piramal Pharma Main Business
Table 110. Piramal Pharma Latest Developments
Table 111. Solara Active Pharma Sciences Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 112. Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 113. Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 114. Solara Active Pharma Sciences Main Business
Table 115. Solara Active Pharma Sciences Latest Developments
Table 116. Camus Pharma Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 117. Camus Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 118. Camus Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 119. Camus Pharma Main Business
Table 120. Camus Pharma Latest Developments
Table 121. Clearsynth Labs Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 122. Clearsynth Labs Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 123. Clearsynth Labs Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 124. Clearsynth Labs Main Business
Table 125. Clearsynth Labs Latest Developments
Table 126. Helsinn Advanced Synthesis Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 127. Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 128. Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 129. Helsinn Advanced Synthesis Main Business
Table 130. Helsinn Advanced Synthesis Latest Developments
Table 131. Procos Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 132. Procos Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 133. Procos Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 134. Procos Main Business
Table 135. Procos Latest Developments
Table 136. Andenex Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 137. Andenex Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 138. Andenex Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 139. Andenex Main Business
Table 140. Andenex Latest Developments
Table 141. Taizhou Crene Biotechnology Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 142. Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 143. Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 144. Taizhou Crene Biotechnology Main Business
Table 145. Taizhou Crene Biotechnology Latest Developments
Table 146. Zydus Animal Health And Investments Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 147. Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 148. Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 149. Zydus Animal Health And Investments Main Business
Table 150. Zydus Animal Health And Investments Latest Developments
Table 151. Wisdom Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 152. Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 153. Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 154. Wisdom Pharmaceutical Main Business
Table 155. Wisdom Pharmaceutical Latest Developments
Table 156. Zhejiang Tiantai Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 157. Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 158. Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 159. Zhejiang Tiantai Pharmaceutical Main Business
Table 160. Zhejiang Tiantai Pharmaceutical Latest Developments
Table 161. Qilu Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 162. Qilu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 163. Qilu Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 164. Qilu Pharmaceutical Main Business
Table 165. Qilu Pharmaceutical Latest Developments
Table 166. Kelun Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 167. Kelun Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 168. Kelun Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 169. Kelun Pharmaceutical Main Business
Table 170. Kelun Pharmaceutical Latest Developments
Table 171. Hansoh Pharma Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 172. Hansoh Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 173. Hansoh Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 174. Hansoh Pharma Main Business
Table 175. Hansoh Pharma Latest Developments
Table 176. Luoxin Pharmaceuticals Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 177. Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 178. Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 179. Luoxin Pharmaceuticals Main Business
Table 180. Luoxin Pharmaceuticals Latest Developments
Table 181. Hangzhou Jiuyuan Gene Engineering Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 182. Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 183. Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 184. Hangzhou Jiuyuan Gene Engineering Main Business
Table 185. Hangzhou Jiuyuan Gene Engineering Latest Developments
Table 186. Lianyungang Runzhong Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 187. Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 188. Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 189. Lianyungang Runzhong Pharmaceutical Main Business
Table 190. Lianyungang Runzhong Pharmaceutical Latest Developments
Table 191. Viwit Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 192. Viwit Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 193. Viwit Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 194. Viwit Main Business
Table 195. Viwit Latest Developments
Table 196. Humanwell Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 197. Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 198. Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 199. Humanwell Pharmaceutical Main Business
Table 200. Humanwell Pharmaceutical Latest Developments
Table 201. Shandong Anxin Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 202. Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 203. Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 204. Shandong Anxin Pharmaceutical Main Business
Table 205. Shandong Anxin Pharmaceutical Latest Developments
Table 206. Beijing Sjar Technology Development Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 207. Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 208. Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 209. Beijing Sjar Technology Development Main Business
Table 210. Beijing Sjar Technology Development Latest Developments
Table 211. Sichuan Qingmu Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 212. Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 213. Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 214. Sichuan Qingmu Pharmaceutical Main Business
Table 215. Sichuan Qingmu Pharmaceutical Latest Developments
Table 216. Shandong New Time Pharmaceutical Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 217. Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 218. Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 219. Shandong New Time Pharmaceutical Main Business
Table 220. Shandong New Time Pharmaceutical Latest Developments
Table 221. United Pharma Basic Information, Neurokinin Receptor Antagonists API Manufacturing Base, Sales Area and Its Competitors
Table 222. United Pharma Neurokinin Receptor Antagonists API Product Portfolios and Specifications
Table 223. United Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 224. United Pharma Main Business
Table 225. United Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Neurokinin Receptor Antagonists API
Figure 2. Neurokinin Receptor Antagonists API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurokinin Receptor Antagonists API Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Neurokinin Receptor Antagonists API Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Neurokinin Receptor Antagonists API Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Neurokinin Receptor Antagonists API Sales Market Share by Country/Region (2025)
Figure 10. Neurokinin Receptor Antagonists API Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Fezolinetant
Figure 12. Product Picture of Aprepitant
Figure 13. Product Picture of Rolapitant
Figure 14. Product Picture of Fosaprepitant
Figure 15. Product Picture of Netupitant
Figure 16. Product Picture of Maropitant
Figure 17. Global Neurokinin Receptor Antagonists API Sales Market Share by Type in 2026
Figure 18. Global Neurokinin Receptor Antagonists API Revenue Market Share by Type (2021-2026)
Figure 19. Neurokinin Receptor Antagonists API Consumed inTablets
Figure 20. Global Neurokinin Receptor Antagonists API Market:Tablets (2021-2026) & (Tons)
Figure 21. Neurokinin Receptor Antagonists API Consumed in Capsules
Figure 22. Global Neurokinin Receptor Antagonists API Market: Capsules (2021-2026) & (Tons)
Figure 23. Neurokinin Receptor Antagonists API Consumed in Oral Suspension
Figure 24. Global Neurokinin Receptor Antagonists API Market: Oral Suspension (2021-2026) & (Tons)
Figure 25. Neurokinin Receptor Antagonists API Consumed in Injections
Figure 26. Global Neurokinin Receptor Antagonists API Market: Injections (2021-2026) & (Tons)
Figure 27. Neurokinin Receptor Antagonists API Consumed in Other
Figure 28. Global Neurokinin Receptor Antagonists API Market: Other (2021-2026) & (Tons)
Figure 29. Global Neurokinin Receptor Antagonists API Sale Market Share by Application (2025)
Figure 30. Global Neurokinin Receptor Antagonists API Revenue Market Share by Application in 2026
Figure 31. Neurokinin Receptor Antagonists API Sales by Company in 2026 (Tons)
Figure 32. Global Neurokinin Receptor Antagonists API Sales Market Share by Company in 2026
Figure 33. Neurokinin Receptor Antagonists API Revenue by Company in 2026 ($ millions)
Figure 34. Global Neurokinin Receptor Antagonists API Revenue Market Share by Company in 2026
Figure 35. Global Neurokinin Receptor Antagonists API Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Neurokinin Receptor Antagonists API Revenue Market Share by Geographic Region in 2026
Figure 37. Americas Neurokinin Receptor Antagonists API Sales 2021-2026 (Tons)
Figure 38. Americas Neurokinin Receptor Antagonists API Revenue 2021-2026 ($ millions)
Figure 39. APAC Neurokinin Receptor Antagonists API Sales 2021-2026 (Tons)
Figure 40. APAC Neurokinin Receptor Antagonists API Revenue 2021-2026 ($ millions)
Figure 41. Europe Neurokinin Receptor Antagonists API Sales 2021-2026 (Tons)
Figure 42. Europe Neurokinin Receptor Antagonists API Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Neurokinin Receptor Antagonists API Sales 2021-2026 (Tons)
Figure 44. Middle East & Africa Neurokinin Receptor Antagonists API Revenue 2021-2026 ($ millions)
Figure 45. Americas Neurokinin Receptor Antagonists API Sales Market Share by Country in 2026
Figure 46. Americas Neurokinin Receptor Antagonists API Revenue Market Share by Country (2021-2026)
Figure 47. Americas Neurokinin Receptor Antagonists API Sales Market Share by Type (2021-2026)
Figure 48. Americas Neurokinin Receptor Antagonists API Sales Market Share by Application (2021-2026)
Figure 49. United States Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Neurokinin Receptor Antagonists API Sales Market Share by Region in 2026
Figure 54. APAC Neurokinin Receptor Antagonists API Revenue Market Share by Region (2021-2026)
Figure 55. APAC Neurokinin Receptor Antagonists API Sales Market Share by Type (2021-2026)
Figure 56. APAC Neurokinin Receptor Antagonists API Sales Market Share by Application (2021-2026)
Figure 57. China Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 61. India Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Neurokinin Receptor Antagonists API Sales Market Share by Country in 2026
Figure 65. Europe Neurokinin Receptor Antagonists API Revenue Market Share by Country (2021-2026)
Figure 66. Europe Neurokinin Receptor Antagonists API Sales Market Share by Type (2021-2026)
Figure 67. Europe Neurokinin Receptor Antagonists API Sales Market Share by Application (2021-2026)
Figure 68. Germany Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 69. France Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Neurokinin Receptor Antagonists API Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Neurokinin Receptor Antagonists API Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Neurokinin Receptor Antagonists API Sales Market Share by Application (2021-2026)
Figure 76. Egypt Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Neurokinin Receptor Antagonists API in 2026
Figure 82. Manufacturing Process Analysis of Neurokinin Receptor Antagonists API
Figure 83. Industry Chain Structure of Neurokinin Receptor Antagonists API
Figure 84. Channels of Distribution
Figure 85. Global Neurokinin Receptor Antagonists API Sales Market Forecast by Region (2027-2032)
Figure 86. Global Neurokinin Receptor Antagonists API Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Neurokinin Receptor Antagonists API Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Neurokinin Receptor Antagonists API Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Neurokinin Receptor Antagonists API Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Neurokinin Receptor Antagonists API Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Neurokinin Receptor Antagonists API
Figure 2. Neurokinin Receptor Antagonists API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurokinin Receptor Antagonists API Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Neurokinin Receptor Antagonists API Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Neurokinin Receptor Antagonists API Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Neurokinin Receptor Antagonists API Sales Market Share by Country/Region (2025)
Figure 10. Neurokinin Receptor Antagonists API Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Fezolinetant
Figure 12. Product Picture of Aprepitant
Figure 13. Product Picture of Rolapitant
Figure 14. Product Picture of Fosaprepitant
Figure 15. Product Picture of Netupitant
Figure 16. Product Picture of Maropitant
Figure 17. Global Neurokinin Receptor Antagonists API Sales Market Share by Type in 2026
Figure 18. Global Neurokinin Receptor Antagonists API Revenue Market Share by Type (2021-2026)
Figure 19. Neurokinin Receptor Antagonists API Consumed inTablets
Figure 20. Global Neurokinin Receptor Antagonists API Market:Tablets (2021-2026) & (Tons)
Figure 21. Neurokinin Receptor Antagonists API Consumed in Capsules
Figure 22. Global Neurokinin Receptor Antagonists API Market: Capsules (2021-2026) & (Tons)
Figure 23. Neurokinin Receptor Antagonists API Consumed in Oral Suspension
Figure 24. Global Neurokinin Receptor Antagonists API Market: Oral Suspension (2021-2026) & (Tons)
Figure 25. Neurokinin Receptor Antagonists API Consumed in Injections
Figure 26. Global Neurokinin Receptor Antagonists API Market: Injections (2021-2026) & (Tons)
Figure 27. Neurokinin Receptor Antagonists API Consumed in Other
Figure 28. Global Neurokinin Receptor Antagonists API Market: Other (2021-2026) & (Tons)
Figure 29. Global Neurokinin Receptor Antagonists API Sale Market Share by Application (2025)
Figure 30. Global Neurokinin Receptor Antagonists API Revenue Market Share by Application in 2026
Figure 31. Neurokinin Receptor Antagonists API Sales by Company in 2026 (Tons)
Figure 32. Global Neurokinin Receptor Antagonists API Sales Market Share by Company in 2026
Figure 33. Neurokinin Receptor Antagonists API Revenue by Company in 2026 ($ millions)
Figure 34. Global Neurokinin Receptor Antagonists API Revenue Market Share by Company in 2026
Figure 35. Global Neurokinin Receptor Antagonists API Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Neurokinin Receptor Antagonists API Revenue Market Share by Geographic Region in 2026
Figure 37. Americas Neurokinin Receptor Antagonists API Sales 2021-2026 (Tons)
Figure 38. Americas Neurokinin Receptor Antagonists API Revenue 2021-2026 ($ millions)
Figure 39. APAC Neurokinin Receptor Antagonists API Sales 2021-2026 (Tons)
Figure 40. APAC Neurokinin Receptor Antagonists API Revenue 2021-2026 ($ millions)
Figure 41. Europe Neurokinin Receptor Antagonists API Sales 2021-2026 (Tons)
Figure 42. Europe Neurokinin Receptor Antagonists API Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Neurokinin Receptor Antagonists API Sales 2021-2026 (Tons)
Figure 44. Middle East & Africa Neurokinin Receptor Antagonists API Revenue 2021-2026 ($ millions)
Figure 45. Americas Neurokinin Receptor Antagonists API Sales Market Share by Country in 2026
Figure 46. Americas Neurokinin Receptor Antagonists API Revenue Market Share by Country (2021-2026)
Figure 47. Americas Neurokinin Receptor Antagonists API Sales Market Share by Type (2021-2026)
Figure 48. Americas Neurokinin Receptor Antagonists API Sales Market Share by Application (2021-2026)
Figure 49. United States Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Neurokinin Receptor Antagonists API Sales Market Share by Region in 2026
Figure 54. APAC Neurokinin Receptor Antagonists API Revenue Market Share by Region (2021-2026)
Figure 55. APAC Neurokinin Receptor Antagonists API Sales Market Share by Type (2021-2026)
Figure 56. APAC Neurokinin Receptor Antagonists API Sales Market Share by Application (2021-2026)
Figure 57. China Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 61. India Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Neurokinin Receptor Antagonists API Sales Market Share by Country in 2026
Figure 65. Europe Neurokinin Receptor Antagonists API Revenue Market Share by Country (2021-2026)
Figure 66. Europe Neurokinin Receptor Antagonists API Sales Market Share by Type (2021-2026)
Figure 67. Europe Neurokinin Receptor Antagonists API Sales Market Share by Application (2021-2026)
Figure 68. Germany Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 69. France Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Neurokinin Receptor Antagonists API Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Neurokinin Receptor Antagonists API Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Neurokinin Receptor Antagonists API Sales Market Share by Application (2021-2026)
Figure 76. Egypt Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Neurokinin Receptor Antagonists API Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Neurokinin Receptor Antagonists API in 2026
Figure 82. Manufacturing Process Analysis of Neurokinin Receptor Antagonists API
Figure 83. Industry Chain Structure of Neurokinin Receptor Antagonists API
Figure 84. Channels of Distribution
Figure 85. Global Neurokinin Receptor Antagonists API Sales Market Forecast by Region (2027-2032)
Figure 86. Global Neurokinin Receptor Antagonists API Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Neurokinin Receptor Antagonists API Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Neurokinin Receptor Antagonists API Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Neurokinin Receptor Antagonists API Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Neurokinin Receptor Antagonists API Revenue Market Share Forecast by Application (2027-2032)
